Participates in a prostate cancer research laboratory directed by Dr. Philip Kantoff, at Memorial Sloan Kettering Cancer Institute in New York.
Performing research in different areas relating to the development and progression of prostate cancer including:
studying molecular mechanisms involved in the development of castration resistant prostate cancer and drug resistant metastatic prostate cancer and their application for novel therapeutic designs
looking for predictive genetic markers involved in cancer risk and progression
molecular characterization of cancer characteristics among various patients and linking cancer characteristics and genetic information of individual patients to their disease progression, response to treatments and outcome
the impact of interactions between germline mutations and tumor somatic mutations on prostate cancer development and progression.
M.D. and/or Ph.D. in life sciences. Intelligent, outstanding training background, track record of publications, excellent organizational skills, attention to details, ability to think and work independently, and good interpersonal skills. Knowledge on the analysis of genome wide data sets and cutting edge technologies on CRISPR genome editing and genome epigenetic dynamics will be plus.